HLA-F and cancer: The results indicated that the expressions of TOMM40 were positively correlated with abundance of act CD8, act CD4, CD56, and monocyte cells in most of the cancers and that immuno-inhibitor PVRL2; immuno-stimulators CD276, PVR, TNFRSF18, TNFRSF25, and TNFRSF4; and HLA-A, HLA-B, HLA-C, HLA-F, TAP1, TAP2, and TAPBP molecules were positively correlated with expression of TOMM40 in most of cancers (Supplementary Figure 14).